In addition to being a potential treatmentfor glioblastoma, this recombinant virus could possibly be used against othercancers because many tumor cells express the PVSRIPO receptor antigens (CD155)and have a limited ability to control viral replication. This evidence concerns the gene PVR and neoplasm.